Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1797 of 6351
-
New anthrax vaccine moves forward in human trials
Vaccine OngoingThis randomized, phase 2, double-blinded, multicenter study is designed to assess the safety and immune response kinetics of CYFENDUS™ (henceforth AV7909) administered on 2 primary series vaccination schedules followed by 6- and 12-month boosters.
Phase 2 • Sponsor: Biomedical Advanced Research and Development Authority • Aim: Vaccine
Last updated Jun 27, 2026 09:07 UTC
-
New drug tested before prostate surgery in High-Risk cancer patients
Disease control Recruiting nowTo learn about the safety and effects of a drug called REGN5678 when it is given to patients with high-risk prostate cancer.
Phase 1/2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Aug 27, 2026 00:00 UTC
-
Blood test could personalize chemo for gut cancer patients
Disease control Recruiting nowTo learn if circulating tumor DNA (ctDNA) testing before cytoreductive surgery (CRS) with or without heated intraperitoneal chemotherapy (HIPEC) can show if patients have a low or high risk of the disease returning and help doctors decide if less or more intense chemotherapy is n…
Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
New scan could slash unnecessary prostate biopsies
Diagnosis Recruiting nowThis project aims to evaluate the role of fully hybrid PET/MRI with 18FPSMA and multiparametric MR imaging (mpMRI) as one-stop approach for the diagnosis of clinically significant prostate cancer (csPCa). Our main hypothesis is that adding 18F-PSMA PET to mpMRI prior to biopsy, …
Phase 2 • Sponsor: IRCCS San Raffaele • Aim: Diagnosis
Last updated Jun 27, 2026 12:01 UTC
-
New hope for tough ulcerative colitis cases? experimental drug ALTB-268 enters phase 2 trial
Disease control OngoingALTB-268-201 is a Phase 2a, multicenter, single arm, multiple-dose, open-label study evaluating the efficacy and safety of ALTB-268 in subjects with moderately to severely active UC. The study consists of a Screening Phase, an Induction Phase and a LTE (Long Term Extension)
Phase 2 • Sponsor: AltruBio Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Can Custom-Tailored brain zaps beat tough depression?
Symptom relief PausedThe aim of this study is to explore the effectiveness and safety of different doses of neural regulation under the guidance of pBFS technology in improving symptoms in patients with moderate to severe depressive disorders.
Sponsor: Changping Laboratory • Aim: Symptom relief
Last updated Jun 27, 2026 12:29 UTC
-
Could a prostate cancer drug help fight lung cancer?
Disease control Recruiting nowAndrogen Deprivation Therapy (ADT) triggers thymic revitalization and increases thymic output, enhancing baseline anti-tumor immunity and responses to immunotherapies. Anti-tumor synergism has been identified by combining ADT with anti-PD-1 immunotherapy for androgen-independent …
Sponsor: Jinzhou Medical University • Aim: Disease control
Last updated Jun 26, 2026 14:29 UTC
-
Can we predict who will benefit most from atrial fibrillation ablation?
Knowledge-focused CompletedAtrial fibrillation (AF) is a prevalent cardiac arrhythmia affecting millions globally, with projections indicating a doubling of cases by 2050. AF is linked to heightened cardiovascular risks like stroke and increased healthcare costs. Ablation, targeting the arrhythmia substrat…
Sponsor: Medical University of Warsaw • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:03 UTC
-
Brain zaps could reignite motivation in stroke survivors
Symptom relief CompletedThis pilot study will investigate the safety, feasibility, tolerability, and preliminary efficacy of accelerated high-dose repetitive transcranial magnetic stimulation (rTMS) targeting the medial prefrontal cortex (mPFC) to address apathy symptoms in individuals with chronic stro…
Phase 1 • Sponsor: Medical University of South Carolina • Aim: Symptom relief
Last updated Jul 12, 2026 00:00 UTC
-
Can cholesterol drugs or hormone therapy shield hearts in endometriosis?
Disease control By invitation onlyPurpose: To determine the effects of SERM and simvastatin interventions on endothelial dysfunction in women with endometriosis. Hypothesis: Treatment with the SERM (bazedoxifene + conjugated estrogen) or with simvastatin will decrease systemic inflammation and improve specific m…
Phase 4 • Sponsor: Penn State University • Aim: Disease control
Last updated Jul 29, 2026 00:00 UTC
-
Can tape or electric pulses beat exercise for neck pain?
Disease control CompletedCervical MPS is a condition of pain, weakness and loss of function caused by trigger points located in the tense bands in the muscles in the neck and upper back. Pharmacological and non-pharmacological treatments are used in the treatment of MPS. Although different treatment meth…
Sponsor: Bakirkoy Dr. Sadi Konuk Research and Training Hospital • Aim: Disease control
Last updated Aug 20, 2026 00:00 UTC
-
Can a rough sound reveal how deep anesthesia goes?
Knowledge-focused CancelledThe interest of perioperative cerebral monitoring and in particular electroencephalography (EEG) to reduce neurological and cognitive damage in surgery has been the subject of abundant research and corresponds to a crucial issue. There is increasing evidence to suggest that inade…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Aug 21, 2026 00:00 UTC
-
AI reads 2 million CT scans to spot hidden diseases
Diagnosis OngoingThis study aims to develop an AI-assisted diagnostic system for abdominal contrast-enhanced CT images using data from multiple inpatient centers. In collaboration with Alibaba DAMO Academy, the project will address key mathematical challenges limiting current automated image inte…
Sponsor: First Affiliated Hospital of Zhejiang University • Aim: Diagnosis
Last updated Jun 27, 2026 09:11 UTC
-
Can a crocosmia bulb compound tame type 2 diabetes?
Disease control CompletedThe goal of this clinical trial is to test the investigational product, Montbretin A (MbA) in either individuals with type 2 diabetes (T2D) or healthy participants. The main questions it aims to answer are: * Safety of MbA * Whether MbA has less side effects in comparison to ot…
Phase 1 • Sponsor: Robert Petrella • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
Fighting hunger and HIV: new study tests peer support to tackle food insecurity
Disease control Recruiting nowThe objectives of this study are to better understand how FI (food insecurities) contributes to the development of cardiometabolic comorbidities among PWH (People with HIV) and to test a novel bilingual FI intervention designed to reduce these comorbidities among food insecure PW…
Sponsor: Wake Forest University Health Sciences • Aim: Disease control
Last updated Aug 06, 2026 00:00 UTC
-
One pill to tackle diabetes and cholesterol? new trial underway
Disease control Recruiting nowThe purpose of this study is to evaluate the efficacy and safety of Berlim 25/20 association in the treatment of type 2 diabetes mellitus and dyslipidemia.
Phase 3 • Sponsor: EMS • Aim: Disease control
Last updated Jun 27, 2026 08:02 UTC
-
Hong kong trial tests digital sleep program to stop insomnia before it starts
Prevention Recruiting nowInsomnia is one of the most common sleep disorders and affects approximately 10 - 40% of the population across different age groups in Hong Kong. Our previous study has shown that insomnia can be prevented through a brief cognitive behavioral prevention program in adolescents. Ho…
Sponsor: Chinese University of Hong Kong • Aim: Prevention
Last updated Jun 27, 2026 12:00 UTC
-
Engineered immune cells take on lupus in first human test
Disease control CompletedA Phase 1 clinical trial to evaluate the safety and efficacy of PiggyBac transposon-mediated Chimeric Antigen Receptor(CAR) T-cells targeting CD19 in refractory Systemic Lupus Erythematosus (SLE) patients who have not responded to standard immunosuppressive treatments.
Phase 1 • Sponsor: Chulalongkorn University • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Magic mushroom compound tested for back pain relief
Symptom relief OngoingThis study evaluates whether psilocybin therapy helps patients cope with chronic low back pain more effectively. Patients may be recruited at Stanford and University of California San Francisco (UCSF), study procedures will occur at UCSF. Each participant will receive a dose of p…
Phase 1/2 • Sponsor: Joshua Woolley, MD, PhD • Aim: Symptom relief
Last updated Jun 27, 2026 12:25 UTC
-
CT scan could guide safer blood thinner use after TAVI
Disease control Recruiting nowThe POPular ATLANTIS trial aims to investigate CT-guided antithrombotic therapy compared to lifelong single antiplatelet therapy after a transcatheter aortic valve implantation (TAVI) procedure. Only patients without an indication for anticoagulants will be included in this trial…
Sponsor: St. Antonius Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC